IGF1R and neoplasm: Via employing CRISPRCas9 gene-editing system IRAIN could compete in cis with the overlapping IGF1R promoter, and thereby suppress the IGF1R signaling cascade that in turn attenuate tumor cell proliferation and metastasis in BCa cells.